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Preclinical drug testing should be considered an important stage during 
examinations of its efficiency and safety in any likely indication observed. Purpose of the 
process is acquisition of substantial amount of particular drug-related data before 
approaching clinical trials in humans. Historical preclinical testing relied on available 
testing in microbe cultures and animal models. During recent decades laboratory 
techniques of human cell lines cultivation have been developed and improved. These 
provide unique possibility of drug acting mechanism testing in a simplified environment 
lacking basic homeostatic mechanisms. Some examples of these are measuring drug 
impact to biochemical transport, signaling or anabolic processes. Humane cell lines of 
embrional kidney 293 are an example of easy-to-grow and disseminate and quite 
endurable cell line. This methodological article notices some of the details of HEK293 
cells cultivation and breading. We took transfection as an example of in vitro model 
creation for drug testing. Transfection refers to gene introduction into HEK293 cellular 
genome in order to achieve membrane expression of coded protein. In our case it would 
be human serotonin transporter. Article contains description of one particular 
methodological approach in measuring human serotonin transporter expression. The role 
and importance of serotonin pump in affective disorders genesis was already widely 
recognized. Aim of the paper was to emphasize feasibility of cell cultivation and its 
advantages in comparison with alternative traditional methods. Acta Medica Medianae 
2012;51(2):34-38. 
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Experimental in vitro models of pre-
clinical drug testing 
 
Any experimental substance with a noticeable 
therapeutic potential in a humane disease or 
disorder must pass the long-term preclinical drug 
development cycles. This practice is established on 
the long farmacovigilance world history in 
recognizing the severe drug side effects, registered 
and approved for the humane usage pretermely 
(1). Such compounds were withdrawn from the use 
leaving the serious consequences to the society 
affected by the adverse event and to a company 
which invested the great amount of time and 
resources into the new drug development as well 
(2- 4). 
Fortunatelly for patients, the rapid development 
of applied organic chemistry, physiology and the 
basic pharmacotherapy during the last century and 
a half, provided us with animal models for certain 
diseases. Such are the examples of the induced 
malignant tumors, convulsive disorders or diabetes 
in rodents and lower primates. That way we learn 
to discover more about the efficacy of the observed 
indication and safety of a drug application before 
the first experiments on the humane subjects. 
Furthermore, towards the lower levels of 
hierarchical life the organization by Line`s biological 
classification in-vitro laboratory experiments with 
cultivated organisms followed (5). They could be 
very useful in examination the microbicide effect 
and resistence to antibiotics or, much later, 
mutagenic potential of various drug kinds.  
However, a quite new phase in preclinical 
drug development was set by the possibility of 
extracorporeal mamal cell cultivation under “in-
vitro” circumstances. Early supporters of this 
development noted the advantages of isolated 
observation of biological processes and drug impact 
upon them in the simplified artificial surroundings 
and the absence of most distracting homeostatic 
mechanisms. The very act of cultivating of 
eukaryotic cells “in-vitro”, was developed during 
the last half of the century conducted by the idea 
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sustained and that their metabolism and the 
reaction towards the various external influence 
could be examined (6). The methodology of 
cultivation and reproduction of human cell lines, 
which later became the cultivation of the whole 
tissue, represents one of the basic postulates of the 
experimental biomedicine and the useful tool for 
the development of new diagnostic and therapeutic 
procedures. The present standards of a good 
laboratory practice and relative simplicity of the 
working technique with the cell cultures in vitro are 
the outcome of a long process of improvement of 
their growth medium structure and sterile working 
conditions (6-9). 
 
Humane cell line of embryonic kidney 
293 
 
Most of the animal cells show the ability of 
survival, proliferation and manifestation of certain 
differentiation level in culture phenotype throughout 
several generations, if they are obtained with 
certain conditions considering humidity, tempe-
rature, nutrient presence, oxygenation, adequate 
pH environment and the absence of micro-
organisms. By the way of formation cell lines can 
be roughly divided into primary and continuous. 
The first one was derived from the mechanic 
excision and enzymatic digestion directly from the 
tissue in vivo, and have limited lifetime and they 
are relatively difficult to be kept in vitro (6, 7). 
Continuous lines among which is HEK 293 itself are 
most often the population of monoclonal origin and, 
although they are less differentiated than their 
primary relatives, they can be successfully 
immortalized by oncogenic viruses and actually 
transformed into tumor cells which can be 
indefinitely propagated and diffused in laboratory 
conditions. They are typical for their distinctive 
tendency to mutations and morphological pheno-
type changes (8-10).  
HEK 293 cells are macromorphologically 
similar to fibroblasts and the accurate progenitor 
embrional kidney tissue is not known. Examining 
their genotype and nature and kinds of several 
dozens of proteins that are expressed in cytosol 
and on the membrane and are uniquely charac-
teristic for the neural tissue, Gerry Shaw sets the 
hypothesis about their neural origin which haven`t 
met the consensus of experts (8, 9). We have 
chosen the line mentioned above as the one 
suitable for work, because of the feasible gene  
input for the target protein-transferor of biogenic 
amines, whose behavior can be afterwards 
observed, in vitro, under the influence of xenobiotic 
ligands under the circumstances that are simpler 
than those prevailing in nerve synapses, in vivo. 
 
An example of experimental procedure 
of gene implementation for serotonin membrane 
transporter 
 
  As a chosen example of in vitro methodology 
for the examination of drug effect mechanism, 
serotonin membrane transporter expression was 
observed. The gene that codes the protein above 
by act of transfection is artificially inserted to the 
embryonic kidney cells. Transfection represents the 
implementation of an extraneous genetic material 
which most often codes the target protein by 
means of plasmid or viral vector (9-11). The 
molecule mentioned above is closely related to the 
depression pathogenesis, suicidal behavior, 
impulsive aggression and alcoholism during the last 
20 years (12-18). The assumption that the level of 
expression and/or function of this molecule were 
changed increases the possibility of certain mental 
diseases appearance (15, 16, 19). It is important 
since, being situated on the presynaptic neuron 
membrane, it performs the sudden takeover of the 
serotonin released in exocitosis and that way 
controls its concentration in synaptic gap. Thus it 
affects the duration and the intensity of signal 
transmitted by binding of these endogenous ligands 
to post-synaptic 5HT receptors, seven types of 
them described currently (15, 16, 19-23).  
The affinity of drug binding to SERT is the 
focus of many molecular biological studies. The 
reason for that is the fact that the drug effect 
mechanism of several key drug classes in neuro 
science is based on the pharmacological agonism or 
antagonism of natural biogenic amines role (22). 
The main candidates in this group are 
antidepressants of selective inhibitor serotonin 
reuptake class SSRI (escitalopram, fluvoxamine), 
the later anti-psychotics (zyprasidon), obesity 
treatment drugs (sibutramine), migrene treatment 
drugs (risatriptane, naratriptane), certain anti-
emetics and prokynetics (metoclopramide, cetan-
serine, alosetron, cyproheptadine, tegaserode). 
 
Methodology of rising, scattering and 
trans-fection on HEK293 cells 
 
Consider the authentic, genotypic and morpho-
logically standardized, continuous HEK293 line in 
deeply frozen condition (-190°C). The uniqueness 
of this line is reflected in the fact that it already 
contains the implemented and exprimated gene on 
the serotonin human transporter membrane 
(hSERT). The culture above is to be commercially 
obtained  from a human cell line bank or from an 
academic source such as University Vanderbilt  of 
Nashville, Tennessee, USA, which has a several 
year standardization and work with the line above 
experience ,so that it conceded its lines to other 
centres for the sake of further examination (12, 15, 
19, 24).  
The working procedure consists of the 
sudden line defrosting up to +37 °C which prevents 
the toxicity of cryo preservative by timely 
immersion into nutrient medium. The culture 
mentioned above is adherent, epithelial type, is 
sown on standard PVC Petri dishes of 75cm² 
(Falcon) with the necessary cladding with poly – D - 
lysine and is maintained on the basic DMEM Pharmacological in vitro models in pre-clinical drug testing...                                                                  Mihajlo Jakovljević et al. 
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nutrient medium with the addition of 10 % of fetal 
bovine serum (FCS- GIBCO, Grand Island, NY). For 
passage, and further propagation of the cells during 
growth, it is sufficient to wash the cells with PBS 
buffer (NaCl 0.14mm, 2.7mm KCl, 10mm Na2HPO4, 
KH2PO4 2 m m ,  p H  7 . 4 ) ,  s e p a r a t e  t h e m  f r o m  t h e  
base and make the suspension with commercial 
tripsine of a several minute duration and then 
change the medium for the chosen 10% of cells 
every 72 hours. The other conditions for keeping in 
the incubator considering PH of the environment, 
oxygenation, and resistance to contamination by 
microorganisms do not differ significantly from 
other human immortalized lines (5% CO2, 37°C, pH 
7.4).  
  After entering the phase of stable growth it is 
necessary to obtain the familiar solution concen-
tration of examined hSERT ligands. Exposing the 
cell line to increasing concentrations and exposure 
time of the given compounds, we can measure the 
serotonin pump working tempo (with the known 
expression level) before and after the intervention 
(13, 14, 16, 20, 25). 
Before every experiment, it is needed to 
visually examine the line vitality and provide the 
confluence (thickness) higher than 75%. The 
procedure is started with removing the old medium 
and rinsing the cells in Krebs-Ringer-Hepes buffer 
(KRH: 120 mM ; NaCl, 4.7 mM KCl, 10 mM Hepes, 
1.2 mM MgSO4, 1.2 mM KH2PO4,5 mM Tris, 2.2 mM 
CaCl2) at room temperature. In every Petri dish we 
add 475 µl of KRH buffer, with addition of 1.8g/L of 
glucose (gKRH). When we plan to add the drug, the 
cell will be pre-incubated with the desired agent 
durin 20 minutes at least (at 22°C). Before the 
planned intervention, in order to control it, we 
check the hSERT function. The measuring consists 
of following and the procedure is not significantly 
different whether we have presence or absence of 
experimental factor: 
• Assuming that the synthesis of 5HT in the 
cytosol is negligible in the absence of an essential 
amino acid tryptophan in the medium (as a 
substrate from which forms mentioned trans-
mitter). 
•  We observe the input of extracellulary 
added 5HT in a known concentration (10 µМ of 5HT 
at the the cell population number 3.5-6*105 at 24 
chamber flask), as only or at least dominant source 
of intracellular 5HT. 
• It is necessary to add 50 µМ of pargyline 
and 50 µМ of ascorbic acid in order to prevent the 
intracellular degradation of serotonin input (5HT). 
• After the availability of 5HT to the cells 
during one minute, it is needed to rinse the culture 
two times with cold KRH buffer and change the 
medium for a new one so that the further input 
would be interrupted.  
Here we use another approximation in order 
to simplify the model of serotonin pump function 
examination, and it assumes that its motion is 
approximately one-way influx outwards to inwards, 
i.e. we neglect the biogenic amines efflux  outer 
cells which de facto happens to some extent. 
After the mentioned procedure we approach 
to the analysis of speed and scope of net takeover 
of 5HT by means of fluorescent essay (Neuro-
transmitter Transporter Uptake Assay Kit - R8174, 
MDS)  
The results obtained can be incorporated into 
the simple mathematical model which allows us to 
quantitatively interpret the impact of ligand 
presence on the pump function. 
 
Expected response in the hypothetical 
experiment of this kind 
 
After the exposure of HEK293 with the 
experimental humane SERT on the membrane to 
the compounds with the proven affinity to binding 
to transporter mentioned, the following outcomes 
are assumed for the biogenic amines: 
•  Antidepressant agents of SSRI group, in 
accordance with previously confirmed basic mecha-
nism of their affection in depression pathogenesis, 
in our example, significantly inhibit the SERT 
function (40%) and lower the tempo of 5HT 
reuptake and therefore probably leave the higher 
concentration of this signal molecule in the synaptic 
gaps zone in human brain in vivo. 
•    Different tested antiemetics and pro-
kinetics with the hypothetic basic mechanism of 
their action by means of a few types of 
postsynaptic 5HT receptors upon the neuroendocrin 
digestive tract cells do not disturb to higher extent 
the action of the 5HT transporter so that, it does 
not represent the significant mechanism of their 
action in indications which they are according to the 
majority opinion registered for in some countries. 
•   The influence of antimigraine substances 
of later generation, of confirmed efficiency, does 
not inhibit the hSERT action either, and therefore, 
the mentioned substances require different 
theoretical and experimental foundation of their 
insufficiently known mechanism of action in 
vascular headache genesis. 
 
Future projections of cultivating metho-
dology 
 
The example of routine working methodology 
with one kind of human cell line and transporter of 
one endogenic ligand considered to be crucial in 
many neural diseases genesis was described. In the 
time of increasing interest for stem cell lines this is 
only one of many examples of practical application 
of simple models in pre-clinical drug examination. 
The basic advantage of this cell and tissue 
cultivating is their human origin comparing to the 
work with complex animal models. A distinctive 
specificity complicates the generalization and 
application of the noticed results upon the human 
population. The other advantages are the safety of 
early estimation of observed agent relative 
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detection of some forms of drug toxicity   such as 
mutagenicity and cytotoxicity that is induction of 
apoptosis. The disadvantages of this methodology 
are drastic simplicity considering in vivo conditions 
and the absence of homeostatic mechanisms which 
contrast the drug effect. However, it is up to the 
time and the whole tissue specialization, and 
maybe even the whole organs, to show the 
permanent position of this methodology in the 
development of clinical usage drugs. 
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FARMAKOLOŠKI IN VITRO MODELI ZA PREDKLINIČKO ISPITIVANJE 
LEKOVA - PRIMER  hSERT TRANSFICIRANIH HUMANIH EMBRIONALNIH 
ĆELIJA BUBREGA 
  
Mihajlo Jakovljević i Olivera Milovanović 
 
 
Predkliničko testiranje lekova je važan segment ispitivanja efikasnosti i 
bezbednosti leka u pretpostavljenoj indikaciji. Njegova svrha je u prikupljanju 
značajnog kvantuma informacija o leku pre ulaska u kliničku fazu ispitivanja na 
humanim subjektima. Pored ispitivanja na mikroorganizmima i animalnim modelima 
poslednjih decenija je usvojena tehnologija rada sa kultivisanim ćelijskim linijama 
humanog porekla. One pružaju jedinstvenu mogućnost ispitivanja uticaja leka na 
biohemijske transportne, signalizacione i anaboličke procese u pojednostavljenom 
okruženju sa drastično umanjenim uticajem homeostatskih mehanizama. Humane 
embrionalne ćelije bubreg su primer veoma zahvalne za kultivaciju i relativno otporne 
ćelijske linije. Metodološki rad koji je pred Vama iznosi detalje njihovog uzgajanja i 
rasejavanja. Kao primer stvaranja in vitro modela za testiranje lekova navodimo 
postupak transfekcije. On se odnosi na unošenje gena za membransku ekspresiju 
humanog transportera za serotonin na HEK293 ćelijama. Opisan je standardni 
metodološki pristup merenja ekspresije pomenutog transportera, učinka transfekcije. 
Uloga i značaj rada ”serotoninske pumpe” su već dobro opisani u genezi poremećaja 
raspoloženja. 
Cilj  članka je da ukaže na izvodljivost i prednosti rada sa humanim ćelijskim 
linijama umesto alternativnih prokariotskih i animalnih modela. Acta Medica Medianae 
2012;51(2):34-38. 
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